Showing posts with label Becton Dickinson. Show all posts
Showing posts with label Becton Dickinson. Show all posts

Tuesday 15 December 2015

Becton, Dickinson and Company

Becton, Dickinson and Company
BDX(NYSE)

Sector:  Health Care
Beta Coefficient: 0.87
10 Yr Compound EPS Growth:  11.5%
10 Yr Compound DPS Growth 16.5%


Financial Result Year 2014

Revenues (m)   8,446
Net Income (m)  1,236
EPS  6.25
DPS 2.18
Cash flow per share 9.37
Current yield 1.7%

High Price  142.6  P/E 22.8   DY 1.53%
Low Price  105.2  P/E 16.8   DY  2.07%


Becton Dickinson is one of the premier medical supply and technology companies on the planet.

Becton Dickinson is a global health care company .  The company develops, manufactures, and sells medical supplies, devices, laboratory instruments, antibodies, reagents, and diagnostic products through its three segments:

BD Medical  (54% of FY 2014 sales)
BD Diagnostics (14%)
and
BD Biosciences. (32%)


International sales account for about 59% of the total.

In mid-2014, the company announced the acquisition of CareFusion, a global provider of automated tools and systems designed to reduce patient medication errors and to prevent care-associated infections.

With the acquisition, while accretive, CareFusion may appear to dilute BD;s strong profit margins (NPM for BD is about 15% while CareFusion is about 11%), but it is anticipated synergies and growth to be a net positive.

Its dividend increases are not only steady but large, typically 10% per year, and the company plans to continue that pattern.  Dividend raises, last 10 years: 10 times.


Stock Performance Chart for Becton Dickinson and Co